Revolutionizing orthopedic healthcare: a systematic review unveiling recombinant antimicrobial peptides
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The increasing demand for orthopedic surgeries, including joint replacements, is driven by an aging population and improved diagnosis of joint conditions. Orthopedic surgeries carry a risk of infection, especially in patients with comorbidities. The rise of antibiotic resistance exacerbates this issue, necessitating alternatives like in vitro bioengineered antimicrobial peptides (AMPs), offering broad-spectrum activity and multiple action mechanisms. This review aimed to assess the prevalence of antimicrobial potential and the yield after purification among recombinant AMP families. The antimicrobial potential was evaluated using the Minimum Inhibitory Concentration (MIC) values against the most common bacteria involved in clinical infections. This systematic review adhered to PRISMA guidelines, focusing on in vitro studies of recombinant AMPs. The search strategy was run on PubMed, Scopus and Embase up to 30 th March 2023. The Population, Exposure and Outcome model was used to extract the data from studies and ToxRTool for the risk of bias analysis. This review included studies providing peptide production yield data and MIC values against pathogenic bacteria. Non-English texts, reviews, conference abstracts, books, studies focusing solely on chemical synthesis, those reporting incomplete data sets, using non-standard MIC assessment methods, or presenting MIC values as ranges rather than precise concentrations, were excluded. From 370 publications, 34 studies on AMPs were analyzed. These covered 46 AMPs across 18 families, with Defensins and Hepcidins being most common. Yields varied from 0.5 to 2,700 mg/L. AMPs were tested against 23 bacterial genera, with MIC values ranging from 0.125 to >1,152 μg/mL. Arenicins showed the highest antimicrobial activity, particularly against common orthopedic infection pathogens. However, AMP production yields varied and some AMPs demonstrated limited effectiveness against certain bacterial strains. This systematic review emphasizes the critical role of bioengineered AMPs to cope infections and antibiotic resistance. It meticulously evaluates recombinant AMPs, focusing on their antimicrobial efficacy and production yields. The review highlights that, despite the variability in AMP yields and effectiveness, Arenicins and Defensins are promising candidates for future research and clinical applications in treating antibiotic-resistant orthopedic infections. This study contributes significantly to the understanding of AMPs in healthcare, underscoring their potential in addressing the growing challenge of antibiotic resistance. Systematic review registration:https://osf.io/2uq4c/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antimicrobial peptides (AMPs) have been incorporated into biomaterials for orthopedic implants, showing reduced bacterial colonization and lower post-surgical infection rates [100].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [100]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 2×
“…activity against bacteria (Gram-positive and Gram-negative), viruses (enveloped and non-enveloped), yeasts, fungi, molds, and parasites (Zasloff, 2002; Radek and Gallo, 2007; Marxer et al., 2016); (ii) multiple mechanisms of action on different biological targets to traditional…”
BackgroundSolid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647 · cited 1×
“In chemical production, solid-phase-peptide synthesis is the most common method used, also at industrial scale (Merrifield, 1963).”
MethodAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829 · cited 1×
“…nucleic acids, the binding with the precursor lipid II crucial for the peptidoglycan synthesis, the interaction with different chaperone proteins to block the protein folding pathway, resulting in bacterial death (Otvos et al., 2000; Brogden, 2005; Essig et al., 2014; Mardirossian et al., 2018).”
BackgroundJenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518 · cited 1×
“These peptides usually are less than 100 amino acids long, especially consisting of positively charged (i.e., lysine, arginine, and histidine) and hydrophobic residues, these latter accounting for more than 50% (Jenssen et al., 2006).”
BackgroundAntimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351 · cited 1×
“…the cell surface resulting in the disruption of membrane integrity: in detail, the first essential step of interaction is represented by the electrostatic binding of the positively charged residues of AMPs to the anionic lipids of bacterial cell membrane (Bahar and Ren, 2013; Kumar et al., 2018).”
BackgroundKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190 · cited 1×
“…of action on different biological targets to traditional antibiotics and distinct pathways, thus decreasing the propensity for resistance to occur (Hancock and Chapple, 1999; Zasloff, 2002); (iii) regulation of key immunomodulatory mechanisms in the innate immune system (Al-Rayahi and Sanyi,…”
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060
Shichman, I., Roof, M., Askew, N., Nherera, L., Rozell, J. C., Seyler, T. M., & Schwarzkopf, R. (2023) · JBJS Open Access · doi:10.2106/jbjs.oa.22.00112 · Cited by 677 · cited 1×
“This trajectory is expected to persist, given the aging demographic and the increasing need for joint replacement procedures (Shichman et al., 2023).”
BackgroundAntimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure
Lee, T.-H., N. Hall, K., & Aguilar, M.-I. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150703121700 · Cited by 512
“ToxRTool”, a new tool to assess the reliability of toxicological data
Schneider, K., Schwarz, M., Burkholder, I., Kopp-Schneider, A., Edler, L., Kinsner-Ovaskainen, A., Hartung, T., & Hoffmann, S. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.013 · Cited by 459
Costa, S., Almeida, A., Castro, A., & Domingues, L. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00063 · Cited by 450 · cited 1×
“In this latter case, to reduce toxicity and proteolytic degradation processes, recombinant AMPs are mainly produced as fusion proteins (Vassilevski et al., 2008; Li, 2009; Costa et al., 2014).”
BackgroundRAWGraphs: A Visualisation Platform to Create Open Outputs
Mauri, M., Elli, T., Caviglia, G., Uboldi, G., & Azzi, M. (2017) · Proceedings of the 12th Biannual Conference on Italian SIGCHI Chapter · doi:10.1145/3125571.3125585 · Cited by 427 · cited 1×
“The outcome was described as association between the AMP families and the target bacterial genera represented in an alluvial chart using the online tool www.rawgraphs. io (Mauri et al., 2017).”
MethodInteraction between Heat Shock Proteins and Antimicrobial Peptides
Otvos, O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., & Blaszczyk-Thurin, M. (2000) · Biochemistry · doi:10.1021/bi0012843 · Cited by 370 · cited 1×
“…nucleic acids, the binding with the precursor lipid II crucial for the peptidoglycan synthesis, the interaction with different chaperone proteins to block the protein folding pathway, resulting in bacterial death (Otvos et al., 2000; Brogden, 2005; Essig et al., 2014; Mardirossian et al., 2018).”
BackgroundMicrowave heating in solid-phase peptide synthesis
Pedersen, S. L., Tofteng, A. P., Malik, L., & Jensen, K. J. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15214a · Cited by 332
Bacterial membrane lipids in the action of antimicrobial agents
Epand, R. M., & Epand, R. F. (2011) · Journal of Peptide Science · doi:10.1002/psc.1319 · Cited by 332 · cited 1×
“…negative charge is present on both sides of the bacterial membrane, each strain shows peculiar lipid composition: for example negatively charged phospholipids such as cardiolipin and phosphatidylglycerol can vary from 20% in E. coli to almost 100% in Staphylococcal strains (Epand and Epand, 2011).”
BackgroundA User’s Guide to Cell-Free Protein Synthesis
Gregorio, N. E., Levine, M. Z., & Oza, J. P. (2019) · Methods and Protocols · doi:10.3390/mps2010024 · Cited by 276 · cited 1×
“…strategy in AMPs production, not requiring plasmids and thus avoiding limitations in molecular design; moreover, recent advancements in the protein purification methods from these cell free system platforms, could provide scalable protein synthesis (Gregorio et al., 2019; Khambhati et al., 2019).”
BackgroundAntimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275 · cited 1×
“…against bacteria (Gram-positive and Gram-negative), viruses (enveloped and non-enveloped), yeasts, fungi, molds, and parasites (Zasloff, 2002; Radek and Gallo, 2007; Marxer et al., 2016); (ii) multiple mechanisms of action on different biological targets to traditional antibiotics and…”
BackgroundCombination Effects of Antimicrobial Peptides
Yu, G., Baeder, D. Y., Regoes, R. R., & Rolff, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02434-15 · Cited by 220
Advances of Antimicrobial Peptide‐Based Biomaterials for the Treatment of Bacterial Infections
Li, G., Lai, Z., & Shan, A. (2023) · Advanced Science · doi:10.1002/advs.202206602 · Cited by 208
The greening of peptide synthesis
Lawrenson, S. B., Arav, R., & North, M. (2017) · Green Chemistry · doi:10.1039/c7gc00247e · Cited by 205
Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis
Essig, A., Hofmann, D., Münch, D., Gayathri, S., Künzler, M., Kallio, P. T., Sahl, H.-G., Wider, G., Schneider, T., & Aebi, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.599878 · Cited by 179
Recombinant production of antimicrobial peptides in heterologous microbial systems
Ingham, A. B., & Moore, R. J. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060207 · Cited by 175 · cited 1×
“…Escherichia coli is the most preferred recombinant system, mainly due to its rapid growth and well-known genetic and biochemical properties (Ingham and Moore, 2007): high expression levels and low fermentation cost resulted in high AMPs production yields (Meng et al., 2016; Ashcheulova et…”
BackgroundAntimicrobial peptides from different plant sources: Isolation, characterisation, and purification
Tang, S.-S., Prodhan, Z. H., Biswas, S. K., Le, C.-F., & Sekaran, S. D. (2018) · Phytochemistry · doi:10.1016/j.phytochem.2018.07.002 · Cited by 168 · cited 1×
“Up to now, few AMPs have been isolated from natural producers such as plants, insects, bacteria by applying a number of laborious and expensive extraction and purification steps (Moreira et al., 2011; Tang et al., 2018).”
BackgroundPresence of Medical Comorbidities in Patients With Infected Primary Hip or Knee Arthroplasties
Lai, K., Bohm, E. R., Burnell, C., & Hedden, D. R. (2007) · The Journal of Arthroplasty · doi:10.1016/j.arth.2006.09.002 · Cited by 165
Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli
Li, Y. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20090087 · Cited by 161 · cited 1×
“In this latter case, to reduce toxicity and proteolytic degradation processes, recombinant AMPs are mainly produced as fusion proteins (Vassilevski et al., 2008; Li, 2009; Costa et al., 2014).”
BackgroundMardirossian, M., Pérébaskine, N., Benincasa, M., Gambato, S., Hofmann, S., Huter, P., Müller, C., Hilpert, K., Innis, C. A., Tossi, A., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.02.004 · Cited by 146
Pane, K., Durante, L., Crescenzi, O., Cafaro, V., Pizzo, E., Varcamonti, M., Zanfardino, A., Izzo, V., Donato, A. D., & Notomista, E. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.02.012 · Cited by 138
Zhang, J., Li, F., Wang, Z., & Xiang, J. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.08.013 · Cited by 134
Khambhati, K., Bhattacharjee, G., Gohil, N., Braddick, D., Kulkarni, V., & Singh, V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00248 · Cited by 127
Inoculum effect of antimicrobial peptides
Loffredo, M. R., Savini, F., Bobone, S., Casciaro, B., Franzyk, H., Mangoni, M. L., & Stella, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014364118 · Cited by 123
Physicochemical Features and Peculiarities of Interaction of AMP with the Membrane
Pirtskhalava, M., Vishnepolsky, B., Grigolava, M., & Managadze, G. (2021) · Pharmaceuticals · doi:10.3390/ph14050471 · Cited by 121
Optimization of Antibacterial Peptides by Genetic Algorithms and Cheminformatics
Fjell, C. D., Jenssen, H., Cheung, W. A., Hancock, R. E. W., & Cherkasov, A. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01044.x · Cited by 96 · cited 1×
“In a similar way, genetic algorithms and predictive methods can be used to predict the antimicrobial activity (Kliger, 2010; Fjell et al., 2011).”
MethodBiomedical Engineering, Trends, Research and Technologies
(2011) · InTech eBooks · doi:10.5772/993 · Cited by 92
Insect antimicrobial peptides act synergistically to inhibit a trypanosome parasite
Marxer, M., Vollenweider, V., & Schmid‐Hempel, P. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0302 · Cited by 91
Wiradharma, N., Sng, M. Y. S., Khan, M., Ong, Z. Y., & Yang, Y. Y. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200534 · Cited by 90 · cited 1×
“The amphiphilic α -helix promotes the interaction with cell membranes, thus allowing membrane disruption; in particular, the interaction is facilitated by the presence of cationic and hydrophobic residues on the opposite faces of the helix motif (Wiradharma et al., 2013).”
BackgroundBoone, K., Wisdom, C., Camarda, K., Spencer, P., & Tamerler, C. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04156-x · Cited by 89 · cited 1×
“Moreover, advances in machine learning methods allowed to screen and design candidate AMPs with different 3D-structure and function for experimental evaluation (Hiss et al., 2010; Boone et al., 2021).”
BackgroundLi, L., Wang, J., Zhao, X., Kang, C.-J., Liu, N., Xiang, J., Li, F., Sueda, S., & Kondo, H. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2004.09.006 · Cited by 88
Lee, D. L., Powers, J. P. S., Pflegerl, K., Vasil, M. L., Hancock, R. E. W., & Hodges, R. S. (2004) · Journal of Peptide Research · doi:10.1046/j.1399-3011.2003.00106.x · Cited by 87
Solid-phase synthesis of sulfur containing heterocycles
Kaur, N. (2018) · Journal of Sulfur Chemistry · doi:10.1080/17415993.2018.1457673 · Cited by 80 · cited 1×
“Moreover, an important limitation is represented by the huge need for starting materials (Kaur, 2018).”
BackgroundAntibiotic resistance: calling time on the ‘silent pandemic’
Mendelson, M., Sharland, M., & Mpundu, M. M. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac016 · Cited by 75 · cited 1×
“The antibiotic resistance as a “silent pandemic” draws attention to the gravity of the issue in the context of orthopedic infections (Mendelson et al., 2022).”
BackgroundPeptide based antimicrobials: Design strategies and therapeutic potential
Hazam, P. K., Goyal, R., & Ramakrishnan, V. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.08.006 · Cited by 74 · cited 2×
“In the “carpet model,” at first AMPs are bound parallel to the cell surface thanks to the electrostatic interactions; once the critical concentration is reached, AMPs form micelles resulting in membrane disruption (Hazam et al., 2019).”
BackgroundHerbel, V., Schäfer, H., & Wink, M. (2015) · Molecules · doi:10.3390/molecules200814889 · Cited by 67
Hischebeth, G., Randau, T. M., Ploeger, M., Friedrich, M., Kaup, E., Jacobs, C., Molitor, E., Hoerauf, A. M., Gravius, S., & Wimmer, M. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.08.012 · Cited by 63
Shenkarev, Z. O., Panteleev, P. V., Баландин, С. В., Гизатуллина, А. К., Altukhov, D. A., Finkina, E. I., Kokryakov, V. N., Arseniev, A. S., & Ovchinnikova, T. V. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.092 · Cited by 62
Wang, J., Zhao, X., Liang, Y. L., Li, L., Zhang, W., Ren, Q., Wang, L. C., & Wang, L. Y. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6284-3 · Cited by 51
Srinivasulu, B., Syvitski, R. T., Seo, J.-K., Mattatall, N. R., Knickle, L. C., & Douglas, S. E. (2008) · Protein Expression and Purification · doi:10.1016/j.pep.2008.05.012 · Cited by 49
Qu, H., Chen, B., Hui, P. E. N. G., & Wang, K. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120600 · Cited by 49
All-D-cecropin B: Synthesis, conformation, lipopolysaccharide binding, and antibacterial activity
Bland, J. M., Lucca, A. J. D., Jacks, T., & Vigo, C. B. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007293816634 · Cited by 45
Yang, H., Li, S., Li, F., Lv, X., & Xiang, J. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.06.015 · Cited by 44
Fahimirad, S., Abtahi, H., Razavi, S., Alizadeh, H., & Ghorbanpour, M. (2017) · Molecules · doi:10.3390/molecules22060822 · Cited by 44
Peng, H., Yang, M. S., Huang, W., Ding, J., Qu, H., Cai, J.-J., Zhang, N., & Wang, K. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.09.008 · Cited by 40
Recombinant expression of indolicidin concatamers in Escherichia coli
Morin, K. M., Arcidiacono, S. M., Beckwitt, R., & Mello, C. M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0132-5 · Cited by 37
Meng, F., Zhao, H., Zhang, C., Lü, F., Bie, X., & Lu, Z. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.11.008 · Cited by 36 · cited 1×
“…coli is the most preferred recombinant system, mainly due to its rapid growth and well-known genetic and biochemical properties (Ingham and Moore, 2007): high expression levels and low fermentation cost resulted in high AMPs production yields (Meng et al., 2016; Ashcheulova et al., 2018).”
BackgroundAl-Rayahi, I., & Sanyi, R. H. H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00002 · Cited by 34
Antimicrobial Peptide Precursor Structures Suggest Effective Production Strategies
Kozlov, S. A., Vassilevski, A. A., & Grishin, E. V. (2008) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221308783399261 · Cited by 34 · cited 1×
“In this latter case, to reduce toxicity and proteolytic degradation processes, recombinant AMPs are mainly produced as fusion proteins (Vassilevski et al., 2008; Li, 2009; Costa et al., 2014).”
BackgroundWang, X. J., Wang, X. M., Teng, D., Zhang, Y., Mao, R., & Wang, J. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12246 · Cited by 33
Panteleev, P. V., Myshkin, M. Y., Shenkarev, Z. O., & Ovchinnikova, T. V. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.035 · Cited by 33
Computational approaches to therapeutic peptide discovery
Kliger, Y. (2010) · Biopolymers · doi:10.1002/bip.21458 · Cited by 31 · cited 1×
“In a similar way, genetic algorithms and predictive methods can be used to predict the antimicrobial activity (Kliger, 2010; Fjell et al., 2011).”
MethodConcepts and Applications of “Natural Computing” Techniques in De Novo Drug and Peptide Design
Hiss, J. A., Hartenfeller, M., & Schneider, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164009 · Cited by 29
Arias, M., Hoffarth, E. R., Ishida, H., Aramini, J. M., & Vogel, H. J. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.023 · Cited by 29
Yang, H., Li, S., Li, F., Yu, K., Yang, F.-S., & Xiang, J. (2016) · Marine Drugs · doi:10.3390/md14080152 · Cited by 29
Kaur, N., Dilawari, R., Kaur, A., Sahni, G., & Rishi, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-69039-2 · Cited by 29
Highlights of the 2019 American Joint Replacement Registry Annual Report
Levine, B. R., Springer, B. D., & Golladay, G. J. (2020) · Arthroplasty Today · doi:10.1016/j.artd.2020.09.010 · Cited by 28
Antimicrobial Peptides: Diversity and Perspectives for Their Biomedical Application
Joel, E. O., Aguilar, A. O.-Z. J. A., & Pedro, D. M. (2011) · InTech eBooks · doi:10.5772/13058 · Cited by 27
Xing, L.-W., Tian, S.-X., Gao, W., Yang, N., Qu, P., Liu, D., Jiao, J., Wang, J., & Feng, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3578 · Cited by 23
Moreira, J. S., de Almeida, R. G., Tavares, L. S., Santos, M. D. O., Viccini, L. F., Vasconcelos, I. M., Oliveira, J. T. A., Raposo, N. R. B., Dias, S. C., & Franco, O. L. (2011) · The Protein Journal · doi:10.1007/s10930-010-9299-4 · Cited by 21
Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli
Feng, X., Xing, L.-W., Liu, D., Song, X., Liu, C.-L., Li, J., Xu, W., & Li, Z. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1382-3 · Cited by 21
Jiang, Q. L., Zhang, H., Xie, Y., & Wang, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.07.029 · Cited by 21
Production of the recombinant antimicrobial peptide UBI 18-35 in Escherichia coli
Ащеулова, Д. О., Efimova, L. V., Lushchyk, A. Y., Yantsevich, А. V., Baikov, A. N., & Pershina, A. G. (2017) · Protein Expression and Purification · doi:10.1016/j.pep.2017.10.011 · Cited by 20
Tian, L., Zhang, D., Su, P., Wei, Y., Wang, Z., Wang, P. X., Dai, C. J., & Gong, G. L. (2019) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2018.1476875 · Cited by 20
Production and characterization of a novel antimicrobial peptide HKABF by Pichia pastoris
Wang, L., Lai, C.-E., Wu, Q., Liu, J., Zhou, M., Ren, Z., Sun, D., Chen, S., & Xu, A. (2008) · Process Biochemistry · doi:10.1016/j.procbio.2008.06.009 · Cited by 18
Abiotic Factors Promote Cell Penetrating Peptide Permeability in Enterobacteriaceae Models
Toyohara, D., Yokoi, Y., Inoue, G., Muraoka, T., & Mori, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02534 · Cited by 17
Feng, X., Xu, W., Qu, P., Li, X., Xing, L.-W., Liu, D., Jiao, J., Wang, J., Li, Z., & Liu, C. (2015) · Biotechnology Progress · doi:10.1002/btpr.2041 · Cited by 16
Bottagisio, M., Palombella, S., Lopa, S., Sangalli, F., Savadori, P., Biagiotti, M., Sideratou, Z., Tsiourvas, D., & Lovati, A. B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1056912 · Cited by 16
Self-citationXu, C., Guo, Y., Qiao, X., Shang, X.-Y., Niu, W., & Jin, M. (2017) · Molecules · doi:10.3390/molecules22111963 · Cited by 15
Mo, Q., Fu, A., Lin, Z., Wang, W., Gong, L., & Li, W. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.13079 · Cited by 15
Recombinant expression of sericin-cecropin fusion protein and its functional activity
Thomas, D. S., Manoharan, C., Yashwant, R. S., Mishra, R. K., & Gopalapillai, R. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-02911-3 · Cited by 15
Chen, X., Wen, Y., Li, L., Shi, J., Zhu, Z., Luo, Y., Li, Y., & Chen, R. (2015) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1501.01056 · Cited by 13
Tang, T., Liu, J., Li, S., Li, H., & Liu, F. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.01.030 · Cited by 13
Production and purification of recombinant human hepcidin-25 with authentic N and C-termini
Janakiraman, V. N., Cabanne, C., Dieryck, W., Hocquellet, A., Joucla, G., Sénéchal, C. L., Chaignepain, S., Costaglioli, P., Santarelli, X., Garbay, B., et al. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.12.025 · Cited by 11
Greenshields, A. L., Knickle, L. C., Syvitski, R. T., & Douglas, S. E. (2008) · Protein and Peptide Letters · doi:10.2174/092986608785849281 · Cited by 11
Modification and characterization of a new recombinant marine antimicrobial peptide N2
Yang, N., Wang, X., Teng, D., Mao, R., Hao, Y., Zong, L., Feng, X., & Wang, J. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.03.005 · Cited by 8
Secretory expression of lacticin Q fused with SUMO in Bacillus subtilis
Yu, Z., Wang, Q., Ma, Q., & Zhang, R. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.02.014 · Cited by 7
Büyükkiraz, M. E., & Kesmen, Z. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2262 · Cited by 6
Recombinant Expression and Antibacterial Properties of BmTXKS2 Venom Peptide in Fusion with GST
Taghizadeh, S., Savardashtaki, A., Irajie, C., Rahbar, M. R., & Ghasemi, Y. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10374-5 · Cited by 4
Development and Engineering of CSαβ Motif for Biomedical Application
Yang, Y. (2012) · InTech eBooks · doi:10.5772/19862 · Cited by 3 · cited 1×
“Three or four disulphide bridges stabilize the α -helix/ β -sheet mixed structures, that consist of positively charged residues arranged in the helix and of hydrophobic amino acids in the β -sheet motif (Yang, 2012).”
BackgroundErviana, R., Saengkun, Y., Rungsa, P., Jangpromma, N., MUSTOFA, M., & Daduang, S. (2022) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d231114 · Cited by 3
Research works printed but not linked: 1
- 2024, The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Disk diffusion method for antimicrobial susceptibility testing, version 12.0. 2024
Cited by
Antimicrobial Peptides: Mechanisms, Applications, and Therapeutic Potential
Alzain, M., Daghistani, H., Shamrani, T., Almoghrabi, Y. M., Daghistani, Y., Alharbi, O., Sait, A. M., Mufrrih, M., Alhazmi, W. A., Alqarni, M. A., et al. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s514825 · Cited by 73
Goulian, A. J., Goldstein, B., & Saad, M. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062061 · Cited by 25
“Antimicrobial peptides (AMPs) have been incorporated into biomaterials for orthopedic implants, showing reduced bacterial colonization and lower post-surgical infection rates [100].”
Campoccia, D., Bottau, G., Donno, A. D., Bua, G., Ravaioli, S., Capponi, E., Sotgiu, G., Bellotti, C., Costantini, S., & Arciola, C. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413241 · Cited by 16
Pennone, V., Angelini, E., Šarlah, D., & Lovati, A. B. (2024) · Antibiotics · doi:10.3390/antibiotics13080764 · Cited by 16
“AMPs can be either synthetically produced or derived through recombinant techniques [7], providing versatile platforms for designing targeted anti-infective therapies.”
BackgroundSelf-citationRoy, R. K., Biswas, R., Roy, A., Chandra, R., Shaw, R., Shaw, A. K., & Bandopadhyay, R. (2025) · The Microbe · doi:10.1016/j.microb.2025.100477 · Cited by 9
Metadata
- Authors
- Pennone, V., Rosini, E., Mascheroni, E., Gianola, S., Castellini, G., Bargeri, S., & Lovati, A. B.
- Affiliations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- University of Insubria (IT)
- Corresponding author
- Pennone, Vincenzo
- ORCID
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-04-29
- Volume
- 15
- Pages
- 1370826-1370826
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC11097975
- OpenAlex
- W4396241622
- Cited by
- 8
- References
- 89
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministero della Salute
- Università degli Studi dell'Insubria
- Regione Lombardia
- Fondazione Regionale per la Ricerca Biomedica (3414083 AMPROject, 3414083)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- bone and joint infections, antibiotic resistance, minimum inhibitory concentration, defensins, hepcidin, pathogenic bacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.